Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05903950

Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure

Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure: the APCIQ-BP Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Weill Cornell Medical College in Qatar · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The main objective is to determine if in-home portable air cleaners provide persistent reductions in PM2.5 exposures and improvements in systolic blood pressure and biochemical parameters over 4-weeks in patients with metabolic syndrome residing in Qatar.

Detailed description

Chronic cardio-metabolic diseases such as hypertension and diabetes contribute disproportionately to global morbidity and mortality and are increasing believed to have multiple environmental influences. PM2.5 is the fifth leading risk factor for global mortality - largely due to cardiovascular disease (CVD). Reducing personal exposure to air pollution has shown promise in improving key cardiovascular risk factors (blood pressure and insulin resistance) in limited studies, but durability of these effects is not known. Personal air cleaners have been shown to decrease personal exposure to PM2.5 and reduce blood pressure in small studies and may serve as a pragmatic intervention in high-risk patients in whom air pollution is a strong contributor to cardiovascular health.

Conditions

Interventions

TypeNameDescription
DEVICEAir cleaners with HEPA filterPM 2.5 exposure reduction using in home portable air cleaners fitted with HEPA filters
DEVICEAir cleaners without HEPA filterSimulation of PM 2.5 exposure reduction using in home portable air cleaners without HEPA filters.

Timeline

Start date
2024-11-03
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2023-06-15
Last updated
2025-07-20

Locations

1 site across 1 country: Qatar

Source: ClinicalTrials.gov record NCT05903950. Inclusion in this directory is not an endorsement.